Effects of Haobie Yangyin Ruanjian decoction on hepatic fibrosis induced by carbon tetrachloride in rats

World Journal of Gastroenterology

Volumn 16, Issue 12, 2010, Pages 1458-1464

  Yang, Feng Rui ^a   Fang, Bu Wu ^a   Lou, Jian Shi ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Carbon tetrachloride; Haobie yangyin ruanjian decoction; Hepatic fibrosis; Rat model; Transforming growth factor smad signaling

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALCOHOL; ARTEMISIA ANNUA EXTRACT; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; COLLAGEN TYPE 4; CURCUMA LONGA EXTRACT; EOSIN; HEMATOXYLIN; HYALURONIC ACID; HYDROXYPROLINE; LAMININ; NATURAL PRODUCT; POLYGONUM CUSPIDATUM EXTRACT; PROCOLLAGEN; SALVIA MILTIORRHIZA EXTRACT; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTEMISIA ANNUA; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CURCUMA LONGA; DOWN REGULATION; FEMALE; FOOD INTAKE; GENE EXPRESSION; LIVER FIBROSIS; MALE; NONHUMAN; POLYGONUM CUSPIDATUM; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALVIA MILTIORRHIZA; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TURTLE; WESTERN BLOTTING;

EID: 77950810918     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i12.1458     Document Type: Article

References (29)

1. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250
2. Parsons C.J., Takashima M., Rippe RA. Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepatol 2007; 22 Suppl 1: S79-S84
3. Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 2001; 21: 437-451
4. Tarantino G, Conca P, Riccio A, Tarantino M, Di Minno MN, Chianese D, Pasanisi F, Contaldo F, Scopacasa F, Capone D. Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign? J Transl Med 2008; 6: 72
5. Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 2006; 10: 76-99
6. Jamall IS, Finelli VN, Que Hee SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem 1981; 112: 70-75
7. Gong ZJ, Zhan RZ. Common special staining methods. Pathological technique. Shanghai: Shanghai Science and Technology Press, 1994: 70
8. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372-374
9. Mu YP, Liu P, Long A.H., [Study on pathogenesis of CCl4 induced cirrhosis formation in rats based on the recipe used] Zhongguo Zhongxiyi Jiehe Zazhi 2006; 26: 344-347
10. Safadi R, Friedman SL. Hepatic fibrosis--role of hepatic stellate cell activation. MedGenMed 2002; 4: 27
11. Tahashi Y, Matsuzaki K, Date M, Yoshida K, Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y, Inoue K. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 2002; 35: 49-61
12. Schiller M, Javelaud D, Mauviel A. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci 2004; 35: 83-92
13. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci 2002; 7: d793-d807
14. Feng XH, Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 2005; 21: 659-693
15. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425: 577-584
16. Itoh S, ten Dijke P. Negative regulation of TGF-beta receptor/ Smad signal transduction. Curr Opin Cell Biol 2007; 19: 176-184
17. Runyan CE, Poncelet AC, Schnaper HW. TGF-beta receptor-binding proteins: complex interactions. Cell Signal 2006; 18: 2077-2088
18. Xu L. Regulation of Smad activities. Biochim Biophys Acta 2006; 1759: 503-513
19. Hill CS. Identification of a Smad phosphatase. ACS Chem Biol 2006; 1: 346-348
20. Wicks SJ, Grocott T, Haros K, Maillard M, ten Dijke P, Chantry A. Reversible ubiquitination regulates the Smad/TGF-beta signalling pathway. Biochem Soc Trans 2006; 34: 761-763
21. Verrecchia F, Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 2002; 118: 211-215
22. Verrecchia F, Mauviel A. Control of connective tissue gene expression by TGF beta: role of Smad proteins in fibrosis. Curr Rheumatol Rep 2002; 4: 143-149
23. Liu P, Hu YY, Ni LQ. [On establishing comparative reference system for syndrome classification study from the thinking characteristics of syndrome differentiation dependent therapy] Zhongguo Zhongxiyi Jiehe Zazhi 2006; 26: 451-454
24. Zhang Q, Liu P, Chen HF, Chen L, Cao SH, Liu Y, Wei JJ, Fang ZH, Wu DZ. Multi-analysis of characteristics of traditional Chinese medical syndrome of hepatocirrhosis. Zhongguo Zhongxiyi Jiehe Ganbing Zaizhi 2003; 13: 69-72
25. Lai LN, Fang BW. Effects of artesunate on proliferation of HSCs. Zhongyao Yaoli Yu Linchuang 2006; 22: 25-27
26. Kuang WH, Li JH. Effect of Biejia Jian in preventing rat hepatic fibrosis. Zhongyao Xinyao Yu Linchuang Yaoli 2004; 15: 314-317
27. She SF, Huang XZ, Tong GD. [Clinical study on treatment of liver fibrosis by different dosages of Salvia injection] Zhongguo Zhongxiyi Jiehe Zazhi 2004; 24: 17-20
28. Zhang B, WangLT, ChengJJ, WangZH, ZhaoY. Clinical observation of HuzhangQingganDecoction on chronic hepatitis and on hepatic fibrosis formation. Shanghai Zhongyiyao Daxue Xuebao 2007; 21: 37-39
29. Wang JB, Zhang Y. Clinical application of Curcuma aromatica. Jiangsu Zhongyiyao 2005; 26: 59-61